In This Article:
BEDFORD, Mass., April 29, 2025 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), a biopharmaceutical company committed to redefining the retina experience, today announced participation in several upcoming investor and scientific conferences in the first half of May 2025.
Upcoming Investor Conferences
Citizens JMP Life Sciences Conference 2025:
Fireside Chat Date: Wednesday, May 7, 2025
Fireside Chat Time: 9:00 AM ET
Presenter: Pravin U. Dugel, MD, Executive Chairman, President and CEO
Location: New York, NY
Bank of America 2025 Global Healthcare Conference:
Fireside Chat Date: Tuesday, May 13, 2025
Fireside Chat Time: 9:20 AM PT
Presenter: Pravin U. Dugel, MD, Executive Chairman, President and CEO
Location: Las Vegas, NV
A live webcast of the fireside chats can be accessed by visiting the Ocular Therapeutix website on the Events and Presentations section of the Investor Relations page.
Upcoming Scientific Conferences
Eyecelerator @ Park City 2025:
Park City, Utah
-
Panel Title: Retina in Office
Session 5: I Shall be Released: Novel Drug Delivery Approaches for Glaucoma and Retina
Session Date/Time: Friday, May 2, 2025, 12:30 – 1:30 PM MT
Panelist: Nadia K. Waheed, MD, MPH, Chief Medical Officer
-
Panel Title: Retina in OR
Session 5: I Shall be Released: Novel Drug Delivery Approaches for Glaucoma and Retina
Session Date/Time: Friday, May 2, 2025, 12:30 – 1:30 PM MT
Moderator: Namrata Saroj, OD, Chief Business Officer
-
Company Presentation: Ocular Therapeutix
Session: Retina - TKI and Drug Delivery Showcase
Presentation Date/Time: Friday, May 2, 2025, 1:38 – 1:45PM MT
Presenter: Sanjay Nayak, MBBS, PhD, Chief Strategy Officer
The Association for Research in Vision and Ophthalmology (ARVO) 2025:
Salt Lake City, Utah
-
Presentation Title: Longitudinal quantitative ultra-widefield retinal leakage assessment following a single axitinib hydrogel injection (OTX-TKI) from the HELIOS trial for diabetic retinopathy
Session Date/Time: Tuesday, May 6, 2025, 1:45 – 2:00 PM MT
Location: Ballroom F (Presentation #3311)
Presenter: Neal Shah, MD
-
Poster Title: Target and selectivity profiling of axitinib in cell-based and biochemical assays
Session Date/Time: Thursday, May 8, 2025, 11:45 AM – 1:30 PM MT
Location: Hall A-E (Poster #A0179)
Presenter: Chintan Patel, PhD, Director, Nonclinical Development
-
Poster Title: Macular volumetric fluid outcomes following intravitreal axitinib hydrogel injection (OTX-TKI) in non-proliferative diabetic retinopathy
Session Date/Time: Thursday, May 8, 2025, 2:00 – 3:45 PM MT
Location: Hall A-E (Poster #A0138)
Presenter: Amy Tang